–
AEON Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.94
FY22:
−48.4
FY23:
–
FY24:
73.0
FY25:
−12.8
(positive)
millions USD
FY21:
–
FY22:
−48.4
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.20
FY22:
−52.6
FY23:
–
FY24:
42.0
FY25:
−39.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.20
FY22:
−52.6
FY23:
–
FY24:
42.0
FY25:
−39.2
All amounts in millions USD